- Zika Research Grant Initiative
- Florida’s System for Cancer Research and Collaboration
- Research on Cancer and Tobacco-related Diseases
- Research on Alzheimer’s Disease
- Funding Opportunity Announcements
- List of Active Research Projects
- Cancer Center of Excellence Designation
- Human Research Protection Program and Institutional Review Board (IRB)
- Submit IRB Applications
- Information for Research Participants
- Research Excellence Initiative
- Florida Health Grand Rounds
Public Health Research
UPDATE ON THE AVAILABILITY OF ZIKA VIRUS RNA SAMPLES
Earlier in the funding cycle the Department received a question regarding the availability of samples collected by the Florida Department of Health. The original answer is copied below. The highlighted portion contains an update regarding the availability of Zika virus RNA.
Will researchers have access to samples obtained in the Florida Department of Health Zika surveillance activities? The Department is looking into the mechanism to make samples collected during our investigation and surveillance activities available to researchers (e.g., consent). At the moment, the Department is not making biological specimens or patient information available for research and will not be recruiting or enrolling study participants. We have developed a letter for mailing to individuals who test positive for Zika virus infection. The letter includes contact information for research studies in which they can participate. In the future, if you would like your study and contact information to be included in this letter, you will need to send the Department (firstname.lastname@example.org) a copy of the IRB approval from your institution, a brief description of your study, and answer the following questions: What do you need from study participants? Whom should the patient contact?
UPDATE: The Florida Department of Health (department) will provide Florida researchers, upon request and department IRB approval, with Zika virus RNA as resources permit.
- Announcement of Amendment #2 to the FY 2016-2017 Zika Research Grant Initiative Funding Opportunity Announcement (FOA)
- Announcement of Amendment to the FY 2016-2017 Zika Research Grant Initiative Funding Opportunity Announcement (FOA)
The deadline to submit programmatic questions regarding the Zika Research Grant Initiative has been extended to November 9, 2016. We will post answers to questions to the Initiative website http://www.floridahealth.gov/provider-and-partner-resources/research/zika-research.html) by November 10, 2016. Please submit questions in writing to Research@flhealth.gov by 5:00 p.m. EST on Wednesday, November 9, 2016.
The Florida Department of Health is preparing to release a Funding Opportunity Announcement (FOA) in response to Governor Scott's authorization of $25 million for Zika research. We encourage you to inform researchers at your institution about this this new opportunity and watch for emails with further information in the near future. The focus of this research grant funding is noted in the press release linked above. If you have any questions, please send them to Research@flhealth.gov.
The Unit administers the following programs and initiatives:
- Announcement of Amendment to the FY 2016-2017 James and Esther King FOA
- FAQ's for the Ed and Ethel Moore Alzheimer's Disease Research Program (as of April 2016)
- List of FY 15-16 Awards
- Press Release - January 28, 2016
- Announcement of Funding Opportunity
The Human Research Protection Program, including a committee called an Institutional Review Board that ensures research is ethical and that participants in all research at the Department of Health are protected.
Cancer Center of Excellence Award is a program created in the 2013 Session intended to improve the quality of cancer care by recognizing hospitals, treatment centers, and other providers in this state which demonstrate excellence in patient-centered coordinated care for persons undergoing cancer treatment and therapy in this state.
The Florida System for Cancer Research and Collaboration , an initiative designed to develop a premier research network in Florida, make Florida the designation for cancer care, and integrate public health and private sector cancer prevention efforts.